Kumar S - Search Results

1

Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis.

Kumar S, Lu B, Davra V, Hornbeck P, Machida K, Birge RB. Kumar S, et al. Mol Cancer Res. 2018 Jan;16(1):173-183. doi: 10.1158/1541-7786.MCR-17-0242. Epub 2017 Oct 3. Mol Cancer Res. 2018. PMID: 28974561

2

Crk at the quarter century mark: perspectives in signaling and cancer.

Kumar S, Fajardo JE, Birge RB, Sriram G. Kumar S, et al. J Cell Biochem. 2014 May;115(5):819-25. doi: 10.1002/jcb.24749. J Cell Biochem. 2014. PMID: 24356912

3

Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.

Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y, Birge RB. Kimani SG, et al. Among authors: kumar s. Front Immunol. 2014 Nov 10;5:566. doi: 10.3389/fimmu.2014.00566. eCollection 2014. Front Immunol. 2014. PMID: 25426118 Free PMC article. Review.

4

Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.

Kumar S, Lu B, Dixit U, Hossain S, Liu Y, Li J, Hornbeck P, Zheng W, Sowalsky AG, Kotula L, Birge RB. Kumar S, et al. Oncotarget. 2015 Nov 10;6(35):37792-807. doi: 10.18632/oncotarget.6096. Oncotarget. 2015. PMID: 26473374 Free PMC article.

5

Efferocytosis.

Kumar S, Birge RB. Kumar S, et al. Curr Biol. 2016 Jul 11;26(13):R558-R559. doi: 10.1016/j.cub.2016.01.059. Curr Biol. 2016. PMID: 27404247 Free article.

6

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.

Kimani SG, Kumar S, Davra V, Chang YJ, Kasikara C, Geng K, Tsou WI, Wang S, Hoque M, Boháč A, Lewis-Antes A, De Lorenzo MS, Kotenko SV, Birge RB. Kimani SG, et al. Among authors: kumar s. Cell Commun Signal. 2016 Sep 6;14(1):19. doi: 10.1186/s12964-016-0142-1. Cell Commun Signal. 2016. PMID: 27595981 Free PMC article.

7

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.

Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB. Kasikara C, et al. Among authors: kumar s. Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9. Mol Cancer Res. 2017. PMID: 28184013 Free PMC article.

8

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.

Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, Comollo T, Peng Y, Kotenko SV, Sarafianos SG, Bertino JR, Welsh WJ, Birge RB. Kimani SG, et al. Among authors: kumar s. Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908. Sci Rep. 2017. PMID: 28272423 Free PMC article.

9

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.

Kumar S, Calianese D, Birge RB. Kumar S, et al. Immunol Rev. 2017 Nov;280(1):149-164. doi: 10.1111/imr.12587. Immunol Rev. 2017. PMID: 29027226 Free PMC article. Review.

10

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.

Geng K, Kumar S, Kimani SG, Kholodovych V, Kasikara C, Mizuno K, Sandiford O, Rameshwar P, Kotenko SV, Birge RB. Geng K, et al. Among authors: kumar s. Front Immunol. 2017 Nov 10;8:1521. doi: 10.3389/fimmu.2017.01521. eCollection 2017. Front Immunol. 2017. PMID: 29176978 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,041 results

Search Page

Filters